ARCHIVES

Ibrutinib Increases OS, PFS Versus Ofatumumab in Phase III

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

Folic Acid, Vitamins B6 and 12 Do Not Affect Colorectal Adenoma Risk

October 26, 2012

Study Finds High-Risk Women Reluctant To Take Tamoxifen

December 25, 2009

Screening Guidelines: When Scientists Can’t Agree, What’s The Press To Do?

May 15, 1998

Former FDA Commissioner Lester Crawford Pleads Guilty to Filing False Reports About His Ownership of Stocks in Health, Food, Biotech Companies.

October 20, 2006

Richard Bloch, advocate for patient information services, dead at 78.

July 30, 2004

Satraplatin With Prednisone Reduces Risk Of Disease Progression By 33% In Study

March 30, 2007